ANI Pharmaceuticals share price logo

ANI Pharmaceuticals

NASDAQ: ANIP

Small Cap

$76.00

-0.54

(-0.71%)

as on

ANI Pharmaceuticals Stock Performance

as on August 18, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $75.75
    $78.34
    downward going graph

    0.33%

    Downside

    3.08%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $70.15
    $99.50
    downward going graph

    7.70%

    Downside

    30.92%

    Upside

    downward going graph

ANI Pharmaceuticals share price movements today

Previous Close
$76.54
Open
$77.17
Volume
314.4K
Market Cap
$1.8B
Day's Low - High
$75.75 - $78.34
52 Week Low - High
$70.15 - $99.50

ANI Pharmaceuticals Historical Returns

1 Month Return
-3.36 %
3 Month Return
-1.88 %
1 Year Return
-12.5 %
3 Year Return
+ 27.69 %
5 Year Return
+ 168.56 %

ANI Pharmaceuticals Stock Fundamentals & Key Indicators

Check ANI Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.8B

EPS (TTM)

9.2941

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

1.91%

PE Ratio (TTM)

16.68

Industry PE ratio

3.5878260869565217

PEG Ratio

1.06

EBITDA

209.4M

Revenue (TTM)

978.4M

Profit Margin

11.07%

Return On Equity TTM

20.46%

ANI Pharmaceuticals Stock Valuation

Track how ANI Pharmaceuticals P/E has moved over time to understand its valuation trends.

ANI Pharmaceuticals in the last 5 years

  • Overview

  • Trends

Lowest (8.83x)

September 30, 2021

Industry (3.59x)

August 17, 2026

Today (16.68x)

August 17, 2026

Highest (28.77x)

September 30, 2022

LowHigh

Today’s Price to Earnings Ratio: 16.68x

ANI Pharmaceuticals vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of ANI Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$1.8B168.56%16.6811.07%NA
BUY$21.4B145.28%16.5886.14%NA
HOLD$18.6B9.88%-44.5634.83%2.9899999999999998%
BUY$42.7BNA19.814.55%126.42999999999999%
BUY$30.5B-64.28%12.4770.87%2.76%

Stock Returns calculator for ANI Pharmaceuticals Stock including INR - Dollar returns

The ANI Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

ANI Pharmaceuticals investment value today

Current value as on today

₹95,205

Returns

-₹4,795

(-4.79%)

Returns from ANI Pharmaceuticals Stock

-₹13,113 (-13.11%)

Dollar Impact

₹8,318 (+8.32%)

Analyst Recommendation on ANI Pharmaceuticals Stock

Based on 6 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 6 analysts, 83.33333333333334% of analysts recommend a 'BUY' rating for ANI Pharmaceuticals. Average target price of $108.38

ANI Pharmaceuticals Share Price Target

Get share price movements and forecasts by analysts on ANI Pharmaceuticals.

What analysts predicted

29.88%UPSIDE

Target Price

$108.38

Current Price

$76

Analyzed by

6 Analysts

Target

$108.38

ANI Pharmaceuticals target price $108.38, a slight upside of 29.88% compared to current price of $76. According to 6 analysts rating.

Indian Investors' Interest in ANI Pharmaceuticals Stock

Search interest for ANI Pharmaceuticals Stock has decreased by -22% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-22% versus previous 30 day period

ANI Pharmaceuticals Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
137
138
148
190
197
211
227
247
237
266
Gross Profit
88
80
85
110
124
136
111
237
122
165
Operating Income
20
5
-20
-4
26
13
22
48
38
40
EBITDA
44
17
-13
14
48
39
61
76
57
60
Interest Expense
4
4
2
6
8
8
4
22
3
3
Depreciation
14
14
15
22
22
23
22
22
20
19
Income Before Tax
25
-2
-31
-13
19
10
33
31
40
37
Income Tax Expense
7
-
-7
-3
4
1
7
3
10
12
Net Income
18
-2
-24
-10
15
8
24
27
29
24
Net Profit Margin
13.25%
-1.66%
-16.29%
-5.39%
7.95%
4.04%
10.59%
11.13%
12.42%
9.29%

ANI Pharmaceuticals Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
128
176
201
206
208
216
316
486
614
883
Gross Profit
79
97
128
143
121
115
177
305
364
450
Operating Income
20
28
35
16
-16
-39
-35
46
0
81
EBITDA
56
57
69
60
28
3
25
106
63
207
Interest Expense
11
12
14
12
9
11
28
26
17
20
Depreciation
-
27
33
44
44
47
56
60
67
91
Income Before Tax
8
16
20
3
-25
-56
-62
19
-22
95
Income Tax Expense
4
17
4
-2
-3
-13
-14
1
-3
17
Net Income
3
-1
15
6
-22
-42
-47
18
-18
78
Net Profit Margin
3.06%
-0.61%
7.69%
2.95%
-10.82%
-19.71%
-15.14%
3.86%
-3.01%
8.87%

ANI Pharmaceuticals Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-2
-24
-10
15
8
26
27
27
26
Operating Cash Flow
17
12
15
34
75
44
30
58
56
Investing Cash Flow
-4
-398
-10
-19
-6
-6
-1
-11
-3
Financing Cash Flow
-1
291
-4
-9
-1
6
-4
-21
-4
Change in Cash
11
-95
0
4
67
44
22
25
49

ANI Pharmaceuticals Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-1
15
6
-22
-42
-47
18
-18
78
Operating Cash Flow
39
67
45
15
3
-31
118
64
185
Investing Cash Flow
-107
-27
-27
-68
-105
-15
-18
-404
-34
Financing Cash Flow
72
-27
1
-1
194
-5
67
264
-9
Change in Cash
3
11
19
-54
92
-52
167
-76
140

Mutual Funds that own ANI Pharmaceuticals Stock

Check out the Mutual Funds with significant holdings in ANI Pharmaceuticals.

Funds
Holdings
Shares Held
EMPOWER FUNDS, INC.
0.323893%
73636
VANGUARD ADMIRAL FUNDS
0.271132%
61641
Old Westbury Funds Inc
0.253894%
57722
VANGUARD WORLD FUND
0.235983%
53650
VANGUARD INDEX FUNDS
3.53018%
802573

Global Institutional Holdings in ANI Pharmaceuticals

Funds
Holdings
SPDR
2.01%
Invesco
1.57%
Dimensional
1.29%
Janus Henderson
0.32%
iShares
9.61%

ANI Pharmaceuticals News & Key Events

  • img

    Today's Timeline - 04 May

    Mon, 07:24 PM

    -

    ANI Pharmaceuticals has a +7.81% Earnings ESP and Zacks Rank #3, with earnings report scheduled for May 8.

Insights on ANI Pharmaceuticals

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, ANIP stock has moved up by 2.0%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 237.46M → 266.04M (in $), with an average increase of 10.7% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, United Therapeutics Corporation Common Stock has given 61.9% return, outperforming this stock by 77.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation Common Stock has given 121.3% return, outperforming this stock by 94.0%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 29.49M → 24.71M (in $), with an average decrease of 16.2% per quarter

About ANI Pharmaceuticals

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
OrganisationANI Pharmaceuticals
Headquarters210 Main Street West, Baudette, MN, United States, 56623
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Nikhil Lalwani
E-voting on sharesClick here to vote

Key Management of ANI Pharmaceuticals

Name

Title

Ms. Meredith W. Cook J.D.

Senior VP, General Counsel & Corporate Secretary

Mr. Christopher K. Mutz

Senior VP & Head of Rare Disease

Mr. Muthusamy Shanmugam MS R.Ph.

Head of R&D, COO of New Jersey Operations & Director

Ms. Elizabeth Powell J.D.

Chief Compliance Officer & Head of Legal of Rare Disease

Dr. Mary Pao M.D., Ph.D.

Chief Medical Officer

Mr. Nikhil Lalwani

President, CEO & Director

Mr. Stephen P. Carey

Senior VP of Finance & CFO

Mr. Ori Gutwerg

Senior Vice President of Generics

Mr. Chad Gassert

Senior Vice President of Corporate Development & Strategy

Ms. Krista L. Davis

Senior VP & Chief Human Resources Officer

FAQs

What is ANI Pharmaceuticals share price today?

ANI Pharmaceuticals share price today is $76.00 as on at the close of the market. ANI Pharmaceuticals share today touched a day high of $78.34 and a low of $75.75.

What is the 52 week high and 52 week low for ANI Pharmaceuticals share?

ANI Pharmaceuticals share touched a 52 week high of $99.50 on and a 52 week low of $70.15 on . ANI Pharmaceuticals stock price today i.e. is closed at $76.00,which is 23.62% down from its 52 week high and 8.34% up from its 52 week low.

What is ANI Pharmaceuticals's market capitalisation today?

ANI Pharmaceuticals market capitalisation is $0.00T as on .

How to invest in ANI Pharmaceuticals Stock (ANIP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for ANI Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in ANI Pharmaceuticals Shares that will get you 0.0197 shares as per ANI Pharmaceuticals share price of $76.00 per share as on August 18, 2026 at 8:45 am IST.

What is the minimum amount required to buy ANI Pharmaceuticals Stock (ANIP) from India?

Indian investors can start investing in ANI Pharmaceuticals (ANIP) shares with as little as ₹95.67 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹956.70 in ANI Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ). Based on ANI Pharmaceuticals share’s latest price of $76.00 as on August 18, 2026 at 8:45 am IST, you will get 0.1316 shares of ANI Pharmaceuticals. Learn more about fractional shares .

What are the returns that ANI Pharmaceuticals has given to Indian investors in the last 5 years?

ANI Pharmaceuticals stock has given 168.56% share price returns and 28.7% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?